吴氏分型指导手术策略对衰弱性左侧肝细胞癌患者手术结局的影响
这项回顾性队列研究纳入258例衰弱性左侧肝细胞癌患者,按手术方式分为吴氏分型组(104例)和传统组(154例),经1:1倾向评分匹配后各93例。吴氏分型组术中出血量、输血率、Clavien-Dindo≥3级并发症发生率、术后住院时间和住院费用均显著低于传统组,无复发生存期无显著差异,但总生存期显著更高(P=0.004)。
要点
- 吴氏分型指导手术可减少衰弱性左侧肝癌患者术中出血和输血。
- 吴氏分型组术后严重并发症更少、住院时间更短、费用更低。
- 吴氏分型组总生存期显著优于传统组,无复发生存期无差异。
核心结论
- 吴氏分型指导的手术策略与解剖性切除、更小创伤、更少术后并发症、更低医疗费用及更长长期生存相关。
研究设计与样本
- 回顾性队列研究,纳入2009至2021年258例衰弱性左侧肝细胞癌患者,按手术方式分为吴氏分型组104例和传统组154例,采用1:1倾向评分匹配后各93例。
主要发现
- 吴氏分型组术中出血量显著低于传统组(P < 0.001)。
- 吴氏分型组输血率显著低于传统组(P = 0.018)。
- 吴氏分型组Clavien-Dindo≥3级并发症发生率显著低于传统组(P = 0.014)。
- 吴氏分型组术后住院时间显著短于传统组(P < 0.001),住院费用显著低于传统组(P = 0.035)。
- 两组无复发生存期无显著差异,吴氏分型组总生存期显著更高(P = 0.004);医院衰弱风险评分为总生存期的独立危险因素(HR = 1.672,95% CI 1.498-1.866,P < 0.001)。
临床怎么用
- 对衰弱性左侧肝细胞癌患者,可考虑采用吴氏分型指导手术策略以改善围术期结局和长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty often indicates a poor prognosis after hepatectomy. This study aims to compare the short-term and long-term prognostic impacts of the Wu's classification group and the traditional group in treating left-sided hepatocellular carcinoma patients with frailty. METHODS: This retrospective cohort study analyzed 258 patients with left-sided hepatocellular carcinoma with frailty from 2009 to 2021, who were divided into a Wu's classification group and a traditional group based on surgical approach. Propensity score matching (PSM, 1:1) was used to minimize baseline differences and reduce selection bias. Perioperative outcomes, overall survival (OS), and recurrence-free survival (RFS) were evaluated. Kaplan-Meier survival analysis was performed to compare OS and RFS between the two groups, and Cox regression models were applied to identify independent prognostic factors. RESULTS: A total of 258 patients were included in the analysis cohort. Among them, 104 patients were assigned to the Wu's classification group, and 154 patients to the traditional group. After PSM, 186 patients were matched, with 93 patients in each group. The Wu's classification group demonstrated significantly lower intraoperative blood loss (P < 0.001), blood transfusion rate (P = 0.018), incidence of Clavien-Dindo grade ≥ 3 complications (P = 0.014), postoperative hospital stay (P < 0.001), and hospitalization costs (P = 0.035) compared with the traditional group. No significant difference in RFS was observed between the two groups, while the Wu's classification group demonstrated significantly higher OS (P = 0.004). Hospital frailty risk score (HR = 1.672, 95% CI 1.498-1.866, P < 0.001) were independent risk factors for OS. CONCLUSIONS: Wu's classification-guided surgical strategy is associated with anatomical resection, less invasiveness, fewer postoperative complications, lower medical costs, and longer long-term survival among frail patients with left-sided HCC.
引用
- Mao T, Feng D, Xie Q, et al. Association of surgical strategy guided by Wu's classification with surgical outcomes in left-sided hepatocellular carcinoma patients with frailty. Surg Endosc. 2026. PMID: 42839067. doi:10.1007/s00464-026-13415-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。